工作经历 |
2014.7至今 九州网页版,九州(中国)官方 2012.7-2014.7 YWK国际商事会社和夏化学(太仓)有限公司. 2011.9-2012.6 贵州威门药业股份有限公司. 2011.6-2011.9 重庆华邦制药股份有限公司. 2006.9—2007.8 上海科胜药物研发有限公司. 2004.7--2006.7 无锡药明康德新药开发有限公司. 1998.8--2001.9 贵州省、中科院天然产物化学重点实验室. |
(1)Lammerts van Bueren, A. Ardèvol, J. Fayers-Kerr,B. Luo, Y. Zhang, M. Sollogoub, Y. Blériot, C. Rovira, G. J. Davies,Analysis of the reaction coordinate of α−L fucosidases: a combined structural and quantum mechanical approachA.J. Am. Chem. Soc.2010,132, 1804-1806.(SCI) (2)Bo Luo,Filipa Marcelo,Jérôme Désiré, Yongmin Zhang,Matthieu Sollogoub,Atsushi Kato,Isao Adachi, F. Javier Cañada,Jesús Jiménez-Barbero,Yves Blériot,Synthesis, conformational analysis and evaluation as glycosidase inhibitors of two ether-bridgediminosugars.J. Carb. Chem.2011,30, 641-654.(SCI) (3) Anh Tuan Tran ;Bo Luo; Yerri Jagadeesh; Nicolas Auberger; JérômeDésiré; Shinpei Nakagawa; Atsushi Kato; Yongmin Zhang; Yves Blériot; Matthieu Sollogoub,Synthesis of pyrrolidine-based analogues of 2-acetamidosugars as N-acetyl glucosaminidase inhibitors Carbohydrate Research 2015,40956~62.(SCI) (4) Y. Jagadeesh ; A. T. Tran;Bo Luo; N. Auberger; J. Desire; S.Nakagawa; A. Kato; Yongmin Zhang; M. Sollogoub; Y. Blériotγ-Aminoalcoholrearrangement applied to pentahydroxylated azepanes provides pyrrolidines epimeric to homoDMDP Organic and Biomolecular Chemistry 201513(28)3446~3456.(SCI) |